“Are we going to see that pop up with hundreds of thousands and millions of patients on these prescription drugs?” he questioned. But probably, he reported, the benefits “in all probability nevertheless outweigh the danger.”These exact recommendations also propose using another medication, such as a GLP-one agonist like Ozempic or Trulicity